Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1NET 1Endocrine 1

Conditions

Colorectal Neoplasms 96Rectal Neoplasms 42Colonic Neoplasms 38Stomach Neoplasms 31Pancreatic Neoplasms 31Neoplasm Metastasis 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Neoplasms 21Esophageal Neoplasms 19Burkitt Lymphoma 15Adenocarcinoma Of Esophagus 14Lymphoma 13Leukemia 8Adenocarcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Osteosarcoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Biphenotypic, Acute 4Gastrointestinal Neoplasms 4Gallbladder Neoplasms 4Carcinoma, Hepatocellular 4Liver Neoplasms 3Intestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Bile Duct Neoplasms 3Somatostatinoma 2

Interventions

Temozolomide 3Capecitabine 3Everolimus 2Bevacizumab 2regorafenib 1motesanib diphosphate 1batifiban 1Sorafenib 1Oxaliplatin 1Octreotide 1Leucovorin 1Fluorouracil 1Fentanyl 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Gastrinoma × Leucovorin × Clear all
NCT00227617 2023-05-22

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

University of California, San Francisco

Phase 2/3 Terminated
36 enrolled 14 charts
EndocrineNETThoracic

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Lung Neoplasms, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡